Khang NGUYEN TRIEU

20+ years of tech leadership in digital native companies and more traditional companies going for deep digital transformation. Strong advocate of “Management 3.0 | Agile Leadership Practices” and of “Tech for Good”. My main leadership values: Transparency, Collaboration, Efficiency, Inclusion, Iteration.

What makes me wake up in a good mood every day is to lead Product and Tech / IT teams to:
– Ideate, Design, Build, Operate products and platforms at scale with a positive impact for the company, the society and the planet
– Architect and turn tech organizations & people into a strategic and high performing contributor to the company,
– Execute the digital | agile | devsecops agendas and transformation from C-level to operational level,
– Re-invent themselves by fostering a startup and “intrapreneurial management” mindset.

I also enjoy advising startups which need to scale up in their tech management practices.

Jaleeysa King

Jaleeysa King is a visionary data analyst who is revolutionizing the link between data analysis, fair market value, and diversity in clinical trials. In her previous role as a Senior Data Delivery Analyst at Greenphire, Jaleeysa was responsible for validating the global fair market value data set and providing insight on investigator grant trends to facilitate more effective site budget negotiations. She has since amplified those skills in her current role as a Product Owner driving product innovation. Also, through her in-depth study of the disparities in patient population diversity in clinical trials, she is creating new ways technology and data can be used to bridge those gaps. By providing support to clients through data analysis and industry changes, she continues to find ways to support the broader data vision of Greenphire.

Dave Hine

Dave Hine spent the first half of his career working in the aerospace/defense industry as part of a software development team. While there, he learned about the process, training, and customer support required to make a software solution successful. Today, he applies that experience and passion to clinical trial financial software at Greenphire. He spends his time consulting with sponsors and CROs on the problems, solutions, and impact of payments in clinical trials and also works directly on Greenphire’s innovation team to help them prioritize, design, and deliver new solutions.

Steve Geffon

As Greenphire’s Chief Commercial Officer, Steven Geffon is responsible for the global commercial strategy of the rapidly growing organization, including the execution of sales and marketing programs. Steve joins Greenphire with over 20 years of experience in technology-enabled solutions for life sciences. He has focused much of his career on generating revenue in high-growth businesses, building successful teams, and creating mature commercial business processes. With his extensive experience as a commercial leader, Steven is committed to advocating for transformative technology solutions and building relationships that drive clinical innovation.

Most recently, Steven served as CCO for Science 37, where he led his team through exponential growth in an emerging eClinical category. Before Science 37, he was responsible for sales, marketing, and corporate development as CCO at Medrio, a leading SaaS eClinical technology platform. Additionally, Steven spent nearly 15 years with Clario, leading Commercial Sales for North America encompassing a team of over 100 individuals and over half a billion in annual sales.

Tim Dorsey

Biography Tim Dorsey is a Team Lead of Product Training at Greenphire, whose mission is to ensure all site and sponsor users understand how to effectively use and maximize Greenphire solutions. Tim and his team conduct live trainings, attend Investigator Meetings, and create In-Application training content for users to access within the products. He has been with Greenphire for 4 years and has a decade of training experience prior to this role.

Nick Tresnowski

Nick is the Director of Operations at Leapcure. Leapcure’s mission is to enable equitable clinical trials, aligning the needs of sponsors, sites, and patients. Nick oversees dozens of patient-centric study projects and partnerships, leading the Leapcure team to thousands of impactful, live patient conversations every month, keeping study enrollments on or ahead of schedule. Nick has particular experience synchronizing the interests of patients, sites, and sponsors with rare diseases.

Renee St.Clair

Most recently Renee C. St.Clair, Esq. was In-House Counsel for Valis Biosciences Inc, where she also served at the Regulatory Affairs, Operations, and Compliance Lead.  Ms. St.Clair has over 25 years of legal and regulatory experience advising California employers, is the co-founder of a woman owned law firm based in San Diego, California, and is a specialist in appellate research and writing, including a successful appeal to the U.S. Supreme Court.

Ms. St.Clair pivoted to the life sciences industry hoping to apply her legal skillset to advance science, medicine, and patient outcomes; particularly for patients and veterans struggling with mental health issues.  She has a unique perspective, having been on various sides of the clinical trial process.  Ms. St.Clair provided regulatory guidance at one of the first clinical trial sites in the world to administer psilocybin to participants with depression, has worked with R&D scientists as they developed clinical trial protocols for ketamine, co-drafted IND applications, transitioned a biopharma lab from R&D to GMP-readiness, positioned a biopharma company to obtain state authorization to conduct nonhuman research of Schedule I compounds (DMT, LSD, psilocin, THC, MDMA, 5-MEO-DMT), and currently applies her regulatory background to facilitate Valis Biosciences Inc.’s science based and technology driven clinical trial tools and solutions—often in challenging populations (children) or difficult to measure conditions (mental health and CNS).

Michael Gülck

Michael Gülck has been with Chevron since January 2015. As a Business Development Specialist Michael is responsible for the development of Chevron’s premium gas engine products (HDAX and coolant DELO XLC) in Europe, Africa and Russia.

Michael has been working in the global CHP industry for over 37 years. In this time, he has acquired key knowledge and insight from successful CHP manufacturers across the globe, including Jenbacher and Caterpillar.

Michael has provided international training courses, lectures, and webinars over the last 25 years. Whether electrical integration, hydraulic problems, CHP management, damage analysis or CHP economic considerations, Michael is always available to advise his customers and partners on solutions.